DuoPACT Pilot Intervention

Not Applicable

Completed

• Conditions: HIV/AIDS
• Interventions: Behavioral: DuoPACT; Behavioral: Life Steps

• Registration Number: NCT02181881
• Lead Sponsor: University of California, San Francisco

Brief Summary

The investigators will pilot test the intervention by randomizing 30 couples to one of three conditions: 1) DuoPACT, the newly-developed couples intervention; 2) Life Steps, a standardized antiretroviral adherence intervention for HIV+ individuals; and 3) a treatment as usual (TAU) assessment-only control condition. After randomization, intervention sessions will be delivered weekly (6 DuoPACT sessions, or 3 Life Steps sessions). All couples will be assessed pre/post intervention to evaluate intervention acceptability and feasibility.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-05
• Study First Submitted: 2014-07-02
• Study First Submitted QC: 2014-07-03
• Study First Posted: 2014-07-04
• Primary Completion: 2014-09
• Study Completion: 2014-09
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-13
• Last Update Posted: 2024-02-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

1. Gay male couple.
2. One or both partners must be HIV positive and on antiretroviral medications.

Read More

Exclusion Criteria

Must be able to consent to and follow study protocol.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
DuoPACT	DuoPACT	A 6-session HIV medication adherence support program for couples.
Life Steps	Life Steps	A 3-session HIV medication adherence support program for individuals.

Primary Outcome Measures

Name	Time	Method
Satisfaction with the intervention	3 months	All participants are assessed post intervention to evaluate intervention satisfaction and acceptability.

Secondary Outcome Measures

Name	Time	Method
Feasibility	3 months	All participants are assessed post intervention to evaluate the study's feasibility.

Trial Locations

Locations (1)

Center for AIDS Prevention Studies; 🇺🇸 San Francisco, California, United States